• One-step TUNEL Cy5 Kit: Advancing Apoptosis Assays in Diseas

  2026-06-01

  Discover how the One-step TUNEL Cy5 Apoptosis Detection Kit enables advanced, quantitative apoptosis detection in disease models. This article explores its scientific underpinnings and unique value for programmed cell death research in both tissue and cell-based assays.

• v-Agatoxin-IVA Reveals Overlapping N- and P-Type Ca Channel

  2026-05-31

  Sidach and Mintz’s study challenges the conventional classification of neuronal calcium channels by demonstrating that v-agatoxin-IVA, a spider toxin, exhibits low-affinity blockade of N-type channels alongside its high selectivity for P-type channels. This nuanced pharmacological profile has direct implications for experimental neurophysiology and the interpretation of channel-selective interventions.

• Esflurbiprofen Disrupts SERT-nNOS for Rapid Antidepressant A

  2026-05-30

  The referenced study introduces esflurbiprofen as a novel, fast-onset antidepressant that works by disrupting the SERT-nNOS interaction in the dorsal raphe nucleus. This mechanistic advance offers a promising alternative to traditional SSRIs, with potential for developing more rapid-acting therapies for major depressive disorder.

• Rotigotine Hydrochloride: Optimizing Dopamine D2/D3 Agonist

  2026-05-29

  Rotigotine hydrochloride, a potent dopamine D2/D3 receptor agonist, offers benchmark reliability for Parkinson’s disease and neurodegeneration models. This guide translates analytical advances and experimental insights into actionable protocols, troubleshooting strategies, and comparative advantages for research teams.

• Dovitinib (TKI-258): Transforming RTK Inhibition for Oncolog

  2026-05-29

  This thought-leadership article explores how Dovitinib (TKI-258, CHIR-258) is redefining translational oncology research. By dissecting its multitargeted mechanistic actions, strategic value in tackling tumor heterogeneity, and role in apoptosis induction, we offer a roadmap for researchers navigating the evolving RTK inhibitor landscape. Integrating insights from recent pivotal studies and cross-referencing landmark protocols, we highlight APExBIO’s commitment to empowering next-generation cancer research with Dovitinib.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-05-28

  This dissertation by Hannah R. Schwartz introduces a refined framework for distinguishing between drug-induced proliferative arrest and cell death in cancer cell assays, highlighting the importance of measuring both parameters independently. The work provides a methodological advance with direct implications for the optimization and interpretation of preclinical drug response studies.

• ATF4-Regulated Enhancer Program in Liver Fibrosis: Mechanist

  2026-05-28

  This study uncovers a non-canonical role of ATF4 in driving liver fibrosis by activating an epigenetic enhancer program in hepatic stellate cells. The findings reveal a promising therapeutic target and demonstrate that inhibiting ATF4 translation can effectively reduce fibrotic progression, offering new avenues for interventions in liver disease.

• Sorafenib (BAY-43-9006): Beyond Oncology—A Systems Biology R

  2026-05-27

  Discover how Sorafenib (BAY-43-9006) is redefining its role as a cancer biology research tool and host-targeted antiviral agent. This article explores the latest systems biology insights and practical assay implications, setting it apart from standard antiangiogenic narratives.

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Decoding Immunoge

  2026-05-27

  Discover how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) advances gene expression assays through minimized immunogenicity and enhanced mRNA stability. This article explores unique insights into the interplay of mRNA modification, innate immune suppression, and practical protocol design for robust, reproducible results.

• M344: Histone Deacetylase Inhibitor for Precision Cancer Wor

  2026-05-26

  M344 stands at the forefront of epigenetic modulation, offering potent and tunable inhibition of histone deacetylases for advanced cancer and HIV latency research. This article distills practical workflows, comparative data, and troubleshooting advice, empowering researchers to maximize M344’s translational potential.

• Rotigotine Hydrochloride: Dopamine D2/D3 Agonist in PD Model

  2026-05-26

  Rotigotine hydrochloride stands apart as a versatile dopamine D2/D3 receptor agonist, powering robust modeling of Parkinson's disease and related neurodegenerative syndromes. Its multi-receptor affinity, solubility, and validated in vivo efficacy streamline translational workflows and enable targeted troubleshooting for both motor and non-motor symptom research.

• Calpain Inhibitor I, ALLN: Practical Guide for Research Use

  2026-05-25

  Calpain Inhibitor I, ALLN (SKU A2602) is a potent, selective tool for inhibiting calpain and cathepsin proteases, supporting apoptosis and ischemia-reperfusion models. It is best used in laboratory research workflows that require precise control of protease activity and should not be applied in diagnostic or therapeutic contexts.

• Cyclopamine in Cancer and Development: Epigenetic Insights a

  2026-05-25

  Explore Cyclopamine as a Hedgehog signaling inhibitor, uncovering its advanced role in cancer research and developmental biology. This article uniquely integrates epigenetic considerations and practical assay protocols, offering deeper insights than standard overviews.

• GLP-1 (9-36) amide: Precision Antagonist for GLP-1R Research

  2026-05-24

  GLP-1 (9-36) amide empowers researchers to dissect GLP-1 receptor signaling with unmatched specificity, facilitating advanced metabolic and type 2 diabetes studies. This guide details optimized workflows, troubleshooting strategies, and the foundational science behind its use as a gold-standard antagonist peptide.

• Y-27632 Dihydrochloride: Optimizing ROCK Inhibition in Organ

  2026-05-23

  Y-27632 dihydrochloride enables robust modulation of the Rho/ROCK signaling axis, driving advances in organoid modeling, stem cell viability, and tumor invasion assays. This guide details experimental workflows, troubleshooting strategies, and practical lessons from recent organoid research to help researchers maximize reproducibility and impact.

448 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page